Abstract

Genes encoding the mRNA targets of fragile X mental retardation protein (FMRP) are enriched for genetic association with psychiatric disorders. However, many FMRP targets possess functions that are themselves genetically associated with psychiatric disorders, including synaptic transmission and plasticity, making it unclear whether the genetic risk is truly related to binding by FMRP or is alternatively mediated by the sampling of genes better characterised by another trait or functional annotation. Using published common variant, rare coding variant and copy number variant data, we examined the relationship between FMRP binding and genetic association with schizophrenia, major depressive disorder and bipolar disorder. High-confidence targets of FMRP, derived from studies of multiple tissue types, were enriched for common schizophrenia risk alleles, as well as rare loss-of-function and de novo nonsynonymous variants in schizophrenia cases. Similarly, through common variation, FMRP targets were associated with major depressive disorder, and we present novel evidence of association with bipolar disorder. These relationships could not be explained by other functional annotations known to be associated with psychiatric disorders, including those related to synaptic structure and function. This study reinforces the evidence that targeting by FMRP captures a subpopulation of genes enriched for genetic association with a range of psychiatric disorders.

Highlights

  • Fragile X mental retardation protein (FMRP) binds selected mRNA species to repress their translation [1,2,3,4,5]

  • Since risk to schizophrenia is conferred through structural genetic variants [39, 43, 53, 54] in the form of deletions or duplications of large sections of DNA, we investigated whether Copy number variants (CNVs) from patients with schizophrenia are enriched for genes within bins of probable FMRP targets compared to control subjects

  • In this study we show that genes with high probability of being targets of FMRP are enriched for association with schizophrenia, bipolar disorder and major depressive disorder

Read more

Summary

Introduction

Fragile X mental retardation protein (FMRP) binds selected mRNA species to repress their translation [1,2,3,4,5]. FMRP is highly, and dynamically, expressed in neurons, where it regulates the dendritic synthesis of proteins [6, 7], many of which are modulators of synaptic plasticity [1]. The loss of FMRP function causes fragile X syndrome [8], characterised by abnormal dendritic

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.